Inhibrx Biosciences Inc.
USD87.61
+3.52 (+4.19%)
CEO
Mark Lappe
IPO Date
2024-05-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$83.76
Prev. Close
$84.09
Day Low
$83.75
Day High
$88.64
52W Low
$20.55
52W High
$155.29
Market Cap
$1.29B
Volume
0.14M
| 22 Jan 2025 | JMP Securities | Market Perform | Market Perform | maintain |
| 23 Jan 2024 | JMP Securities | Market Outperform | Market Perform | downgrade |
| 20 Nov 2023 | JMP Securities | Market Outperform | Market Outperform | maintain |
| 23 Aug 2023 | JMP Securities | Outperform | Outperform | maintain |
| 10 May 2023 | JMP Securities | Market Outperform | Outperform | maintain |
| 8 Mar 2023 | JMP Securities | Market Outperform | Market Outperform | maintain |
| 7 Mar 2023 | Credit Suisse | Outperform | Outperform | maintain |